chevron-down Created with Sketch Beta.
May 13, 2022

FDA Narrows Use of Johnson & Johnson COVID-19 Vaccine

On May 5, the FDA limited eligibility for the Johnson & Johnson COVID-19 vaccine to individuals 18 and older for whom other COVID-19 vaccines are not appropriate or available, and to individuals who choose to get the Johnson & Johnson vaccine because they could not otherwise get a COVID-19 vaccine. FDA determined that a risk of developing life-threatening blood clots and low levels of blood platelets within 1-2 weeks of receiving the Johnson & Johnson vaccine justified limiting the eligibility of individuals who can receive it.

The material in all ABA publications is copyrighted and may be reprinted by permission only. Request reprint permission here.